Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ono

Showing results (311-320 of 359) with videos related to

Pageof 36
Sort By:
Mycopathologia|November 24, 2006
Serological detection of antibodies against Paracoccidioides brasiliensis in dogs with leishmaniasisL H Silveira, I H Domingos, K Kouchi, et al.
Medical Mycology|February 3, 2005
Immune response in dogs experimentally infected with Paracoccidioides brasiliensisR C Eisele, L C Juliani, D R Belitardo, et al.
Anticancer Research|September 27, 2015
Imaging and Antitumoral Effect of a Cyclo-oxygenase 2-specific Replicative Adenovirus for Small Metastatic Gastric Cancer LesionsTakashi Kosaka, Julia Davydova, Hidetaka A Ono, et al.
Neoplasma|December 5, 2013
Individual-level data on the relationships of progression-free survival, post-progression survival, and tumor response with overall survival in patients with advanced non-squamous non-small cell lung cancerH Imai, T Takahashi, K Mori, et al.
Radiography (London, England : 1995)|July 5, 2022
Applying patient characteristics, stent-graft selection, and pre-operative computed tomographic angiography data to a machine learning algorithm: Is endoleak prediction possible?T Masuda, Y Baba, T Nakaura, et al.
Cancer Chemotherapy and Pharmacology|January 31, 2014
An open-label, dose-escalation, safety, and pharmacokinetics phase I study of ombrabulin, a vascular disrupting agent, administered as a 30-min intravenous infusion every 3 weeks in Japanese patients with advanced solid tumorsH Murakami, T Kurata, Y Onozawa, et al.
Current Microbiology|May 13, 2021
Distinct Pattern of Paracoccidioides lutzii, P. restrepiensis and P. americana Antigens Recognized by IgE in Human ParacoccidioidomycosisJoão P Assolini, Adriane Lenhard-Vidal, Carla S de O Bredt, et al.
Clinical Nephrology|February 3, 2007
Acute renal infarction in a patient with left atrial myxomaK Fujisaki, Y Shohno, T Yoshida, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|August 3, 2010
Embolization of posterior circulation aneurysms with detachable coilsK Kazekawa, T Fukushima, M Tomonaga, et al.
Neoplasma|February 15, 2012
¹⁸F-FDG uptake on PET could be a predictive marker of excision repair cross-complementation group 1 (ERCC1) expression in patients with thoracic neoplasms?K Kaira, M Endo, T Shukuya, et al.
Pageof 36

Showing results (311-320 of 359) with videos related to

Sort By:
Pageof 36
Mycopathologia|November 24, 2006
Serological detection of antibodies against Paracoccidioides brasiliensis in dogs with leishmaniasisL H Silveira, I H Domingos, K Kouchi, et al.
Medical Mycology|February 3, 2005
Immune response in dogs experimentally infected with Paracoccidioides brasiliensisR C Eisele, L C Juliani, D R Belitardo, et al.
Anticancer Research|September 27, 2015
Imaging and Antitumoral Effect of a Cyclo-oxygenase 2-specific Replicative Adenovirus for Small Metastatic Gastric Cancer LesionsTakashi Kosaka, Julia Davydova, Hidetaka A Ono, et al.
Neoplasma|December 5, 2013
Individual-level data on the relationships of progression-free survival, post-progression survival, and tumor response with overall survival in patients with advanced non-squamous non-small cell lung cancerH Imai, T Takahashi, K Mori, et al.
Radiography (London, England : 1995)|July 5, 2022
Applying patient characteristics, stent-graft selection, and pre-operative computed tomographic angiography data to a machine learning algorithm: Is endoleak prediction possible?T Masuda, Y Baba, T Nakaura, et al.
Cancer Chemotherapy and Pharmacology|January 31, 2014
An open-label, dose-escalation, safety, and pharmacokinetics phase I study of ombrabulin, a vascular disrupting agent, administered as a 30-min intravenous infusion every 3 weeks in Japanese patients with advanced solid tumorsH Murakami, T Kurata, Y Onozawa, et al.
Current Microbiology|May 13, 2021
Distinct Pattern of Paracoccidioides lutzii, P. restrepiensis and P. americana Antigens Recognized by IgE in Human ParacoccidioidomycosisJoão P Assolini, Adriane Lenhard-Vidal, Carla S de O Bredt, et al.
Clinical Nephrology|February 3, 2007
Acute renal infarction in a patient with left atrial myxomaK Fujisaki, Y Shohno, T Yoshida, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|August 3, 2010
Embolization of posterior circulation aneurysms with detachable coilsK Kazekawa, T Fukushima, M Tomonaga, et al.
Neoplasma|February 15, 2012
¹⁸F-FDG uptake on PET could be a predictive marker of excision repair cross-complementation group 1 (ERCC1) expression in patients with thoracic neoplasms?K Kaira, M Endo, T Shukuya, et al.
Pageof 36